Generate Biomedicines, Inc. GENB Conversion Of Convertible Preferred Stock To Common Stock
Other financials
Where this comes from
Reported directly by Generate Biomedicines, Inc. in its filing.
Tagged under the XBRL concept ck0002100782:ConversionOfConvertiblePreferredStockToCommonStock.
The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Generate Biomedicines, Inc. 's conversion of convertible preferred stock to common stock.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Generate Biomedicines, Inc. 's conversion of convertible preferred stock to common stock?
- Generate Biomedicines, Inc. (GENB) reported conversion of convertible preferred stock to common stock of $811.83M in Q1 2026.